Abbott to Invest More in R&D in Emerging Markets, CEO Says
By -
Dec 5, 2011
Abbott Laboratories (ABT) plans to invest more in research and development in emerging markets, Chief Executive Officer Miles White said. He spoke at a Financial Times pharmaceutical industry conference in London.
To contact the reporter on this story: Makiko Kitamura in London at mkitamura1@bloomberg.net
To contact the editor responsible for this story: Phil Serafino at pserafino@bloomberg.net